This article is more than 5 years old. Information may no longer be current.

Carl Zeiss completes IanTECH acquisition

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

IanTECH, the developer of the miLOOP lens fragmentation device, has been fully acquired by Carl Zeiss Meditec, according to corporate communications from Zeiss.

In addition to the miLOOP, IanTECH has other technologies for lens removal under development.

“We expect that IanTECH will complement our leading portfolio of equipment and consumables in cataract surgery, allowing us to offer physicians and patients a new standard of care,” Carl Zeiss Meditec President and CEO Ludwin Monz, PhD, said when the deal was announced in October. “The technology has the potential to simplify challenging cases, reduce risk to patients and further improve outcomes while being easy to train and adapt for surgeons.”